Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NRICM102 Combined With Standard Therapy in Pneumonia
NCT07583992Phase 2Not yet recruiting
- Sponsor
- National Research Institute of Chinese Medicine
- Start
- Jun 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NRICM102 in community acquired pneumonia (CAP), sponsored by National Research Institute of Chinese Medicine. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
NRICM102
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT07583992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07583992.